Lanthanum chloride bidirectionally influences calcification in bovine vascular smooth muscle cells

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1776-1786

  Zhao, Wen Hua ^a   Gou, Bao Di ^b   Zhang, Tian Lan ^b   Wang, Kui ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

APOPTOSIS; CALCIUM PHOSPHATE DEPOSITION; CALCIUM SENSING RECEPTOR; LANTHANUM CHLORIDE; VASCULAR SMOOTH MUSCLE CELLS

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; CALCIUM; CALCIUM SENSING RECEPTOR; CASPASE 3; CASPASE 9; GLYCEROL 2 PHOSPHATE; LANTHANUM CHLORIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; COW; ENZYME INDUCTION; EXPOSURE; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PRECIPITATION; PREVALENCE; PRIORITY JOURNAL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

BOVINAE;

EID: 84859055231     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24049     Document Type: Article

References (43)

1. Aime S, Canavese C, Stratta P,. 2007. Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate. Kidney Int 72: 1162-1163. (Pubitemid 47609045)
2. Alam M, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M, Vizard TN, Sage AP, Martin D, Ward DT, Alexander MY, Riccardi D, Canfield AE,. 2009. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 81: 260-268.
3. Bennett MR, Boyle JJ,. 1998. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138: 3-9. (Pubitemid 28255149)
4. Brambilla S, Valaperta S, Graziani G, Montanelli A,. 2008. Gadolinium and lanthanum: A iatrogenic transmetallation. Clin Biochem 41: 1029-1033.
5. Broe MED,. 2008. Can the risk of gadolinium be extrapolated to lanthanum. Semin Dial 21: 142-144.
6. Carrillo-López N, Fernández-Martín JL, Álvarez-Hernández D, González-Suárez I, Castro-Santos P, Román-García P, López-Novoa JM, Cannata-Andía JB,. 2010. Lanthanum activates calcium-sensing receptor and enhances sensitivity to calcium. Nephrol Dial Transplant 25: 2930-2937.
7. Clarke MCH, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M, Bennett MR,. 2008. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 102: 1529-1538.
8. Davis RL, Abraham JL,. 2009. Lanthanum deposition in a dialysis patient. Nephrol Dial Transplant 24: 3247-3250.
9. Doherty TM,. 2004. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev 25: 629-672. (Pubitemid 39096073)
10. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM, Proudfoot D,. 2008. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: A potential mechanism in atherosclerotic plaque destabilization. Circ Res 103: e28-e34.
11. Fraile P, Cacharro LM, Garcia-Cosmes P, Rosado C, Tabernero aJM,. 2011. Encephalopathy caused by lanthanum carbonate. NDT Plus 4: 192-194.
12. Freitas DD, Donne RL, Hutchison AJ,. 2007. Lanthanum carbonate - A first line phosphate binder? Semin Dial 20: 325-328.
13. Garrett IR, McClure J,. 1981. Lanthanide-induced calcergy. J Pathol 135: 267-275. (Pubitemid 12215918)
14. Giachelli CM,. 2009. The emerging role of phosphate in vascular calcification. Kidney Int 75: 890-897.
15. Hofer MA, Brown EM,. 2003. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4: 530-538. (Pubitemid 36773405)
16. Hofer AM, Lefkimmiatis K,. 2007. Extracellular calcium and cAMP: Second messengers as "third messengers "? Physiology 22: 320-327.
17. Hutchison AJ,. 2009. Oral phosphate binders. Kidney Int 75: 906-914.
18. Hutchison AJ, Laville M,. 2008. Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden. Nephrol Dial Transplant 23: 3677-3684.
19. Hutchison AJ, Barnett E, Krause R, Kwan JTC, Siami GA,. 2008. Long-term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment. Nephron Clin Pract 110: c15-c23.
20. Johannsson Perrault G, Savoie L, Tuchweber B,. 1968. Action of various metallic chlorides on calcaemia and phosphataemia. Br J Pharm Chemother 33: 91-97.
21. Jonge LTd, Beucken JJJPvd, Leeuwenburgh SCG, Hamers AAJ, Wolke JGC, Jansen JA,. 2009. In vitro responses to electrosprayed alkaline phosphatase/calcium phosphate composite coatings. Acta Biomater 5: 2773-2782.
22. Kramsch DM, Aspen AJ, Apstein CS, Memorial E,. 1980. Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. J Clin Invest 65: 967-981.
23. Kubota Y, Takahashi S, Takahashi I, Patrick G,. 2000. Different cytotoxic response to gadolinium between mouse and rat alveolar macrophages. Toxicol In Vitro 14: 309-319. (Pubitemid 30440598)
24. Lacour B, Lucas A, Auchère D, Ruellan N, Patey NMDS, Drüeke TB,. 2005. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int 67: 1062-1069. (Pubitemid 41623331)
25. Leeuw KD, Woestenburg A, Verbeelen D,. 2008. Lanthanum carbonate possibly responsible for acute liver failure in a patient with Child-Pugh stage A liver cirrhosis. NDT Plus 6: 412-413.
26. 2O) transformation in DMEM solutions at 36.5°C. Mater Sci Eng C 30: 245-254.
27. Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T,. 2004. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15: 2579-2587. (Pubitemid 41103364)
28. Moe SM, Chen NX,. 2008. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19: 213-216. (Pubitemid 351240642)
29. Motskin M, Wright DM, Muller K, Kyle N, Gard TG, Porter AE, Skepper JN,. 2009. Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability. Biomaterials 30: 3307-3317.
30. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GFM,. 2009. Benefits and harms of phosphate binders in CKD: A systematic review of randomized controlled trials. Am J Kidney Dis 54: 619-637.
31. Nikolov IG, Joki N, Nguyen-Khoa T, Guerrera IC, Maizel J, Benchitrit J, Reis LMd, Edelman A, Lacour B, Jorgetti V, Drüeke TB, Massy ZA,. 2011. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. Nephrol Dial Transplant DOI: 10.1093/ndt/gfr254.
32. Pennick M, Dennis K, Damment SJP,. 2006. Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate. J Clin Pharmacol 46: 738-746. (Pubitemid 43882797)
33. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL,. 2000. Apoptosis regulates human vascular calcification in vitro: Evidence for Initiation of vascular calcification by apoptotic bodies. Circ Res 87: 1055-1062.
34. Rofsky NM, Sherry AD, Lenkinski RE,. 2008. Nephrogenic systemic fibrosis: A chemical perspective. Radiology 247: 608-612.
35. Saidak Z, Brazier M, Kamel S, Mentaverri R,. 2009. Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications. Mol Pharmacol 761: 1144-2009.
36. Sanyal S, Marckmann P, Scherer S, Abraham JL,. 2011. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis - An autopsy-based review. Nephrol Dial Transplant 26: 3616-3626.
37. Shi Y-L, Wang L-W, Huang J, Gou B-D, Zhang T-L, Wang K,. 2009. Lanthanum suppresses osteoblastic differentiation via pertussis Toxin-sensitive G protein signaling in rat vascular smooth muscle cells. J Cell Biochem 108: 1184-1191.
38. Silver J, Naveh-Many T,. 2009. Phosphate and the parathyroid. Kidney Int 75: 898-906.
39. Smajilovic S, Tfelt-Hansen J,. 2007. Calcium acts as a first messenger through the calcium-sensing receptor in the cardiovascular system. Cardiovasc Res 75: 457-467. (Pubitemid 47080961)
40. Sommer AP,. 2010. Cytotoxicity of calcium phosphate crystals and human-derived nanoparticles: An overlooked link. Circ Res 106: e10.
41. Trion A, Laarse Avd,. 2004. Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J 147: 808-814. (Pubitemid 38880986)
42. Yuan Y, Liu C, Qian J, Wang J, Zhang Y,. 2010. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 31: 730-740.
43. Zhou Y-B, Jin S-J, Cai Y, Teng X, Chen L, Tang C-S, Qi Y-F,. 2009. Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats. Exp Biol Med 234: 908-917.